The East of England Science & Innovation Audit showcases the region’s inventive capabilities

East of England Science and Innovation Audit engineerThe recent East of England Science and Innovation Audit (SIA) makes clear the value to be unlocked through investment in this region with its leading universities and many research organisations. The audit will provide a basis for improving economic performance, identifying opportunities for wider collaboration and investment, as well as catalysing new types of innovation activity.  The report includes a broad-ranging analysis of the region’s capabilities, the challenges and the substantial opportunities for future economic growth.

The East of England SIA was developed by local partners and conducted across the public sector, academia and industry in Cambridge & Peterborough, Essex, Herts, Norfolk & Suffolk. The SIA focused on four themes:

  • Life Sciences
  • Agri-Tech
  • Advanced material and manufacturing
  • ICT

The full East of England Science and Innovation Audit can be downloaded here.

Benefits of the life sciences and healthcare technologies sector in the East of England and Essex region

East of England Science and Innovation Audit buildersThe East of England is a global leader in areas of pharmaceuticals, medical biotechnology and drug delivery and is already an attractor for companies working within the life sciences and healthcare technologies sector. Essex is located at the heart of the London-Stansted-Cambridge innovation corridor, positioning businesses within Europe’s largest life sciences and healthcare technologies cluster.

Essex’s state-of-the-art research and business parks offer fast connections to both Cambridge and London via the M11 motorway. These strategic business locations provide life sciences and healthcare companies with direct access to world-class people, knowledge, funding and collaborative networks, at significantly lower cost than either Cambridge or London can offer.

Essex’s life sciences and healthcare cluster comprises around 300 companies (according to Experian) specialising in the following areas . . .

  • Research, development and manufacture of medical devices
  • Biotechnology
  • Pharmaceutical products and preparations
  • Natural science and engineering research

About the Science and Innovation Audits

East of England Science and Innovation Audit doctorsThe Science and Innovation Audits (SIA) are surveys of cutting edge innovation taking place in industry and the public sector to catalyse a new approach to regional economic development.

 The purposes of the SIA include

  • Informing Central Government of regional strengths and areas of competitive advantage
  • Advising forthcoming science and innovation strategy
  • Generating data to aid future regional investment proposals and foreign direct investment (FDI)

The recent East of England Science and Innovation Audit (SIA) report displays the results of a survey of cutting edge innovation taking place in industry and the public sector to catalyse a new approach to regional economic development.

The full East of England Science and Innovation Audit can be downloaded here.

Dave Russell-Graham
Dave Russell-Graham

Inward Investment Manager (Life Sciences)

+44 (0) 7881 310776

Biography

With over 30 years’ experience in the life sciences and healthcare sector Dave has an extensive range of contacts in the industry as well as experience in pharmaceutical development through to facility refurbishment and fit out. Dave’s work has predominantly been with major pharmaceutical companies, and in 2011 he was a key player in the deal between Pfizer and Mylan for Pfizer’s respiratory technology platform. More recently he has worked as the Scientific Development Advisor for Harlow Science Park.